Access to post-study medicines: status in Brazil and challenges yet to be overcome.

Pharmaceutical Industry – focused on the future

Descentralized clinical studies

The economic impact of the new health technologies

ANVISA – Post-pandemic challenges and perspectives.

What is the purpose of registration submission guide, based on data from scientific literature?

Clinical research in Brazil - regulation is important and urgent!

Psychedelic Drugs - New Opportunities for the Pharmaceutical Market.

Clinical research in Brazil – New horizons, new challenges

ANVISA has just published the new version of the Cadifa Manual, but what were the main changes?

Medicine patents in Brazil – legislative changes and their impacts.

Brazilian regulation prices, and future trends

Innovation - The Driving Force of the Pharmaceutical Industry

Covid 19 vaccines - know the difference between them

Unraveling the Abbreviated Development Path

Publication of the Public Consultation for the review of RDC 200 - what is new?

NEW REGULATORY FRAMEWORK OF API

Six suggestions for a successful Advisory Board

What is the purpose of clinical research on health products?

Incremental innovations - what are the financial benefits?